On the recordMay 3, 2021
H.R. 3 gives the Secretary of Health and Human Services the ability to negotiate lower drug prices directly with drug manufacturers on high-cost prescription drugs that don't have any competition.
Source
congress.govH.R. 3 gives the Secretary of Health and Human Services the ability to negotiate lower drug prices directly with drug manufacturers on high-cost prescription drugs that don't have any competition.
Pallone describes H.R. 3's provisions for negotiating drug prices.
Share
More from Frank Pallone
I stand firmly in support of the brave detainees inside the facility—and the protesters outside—who are standing up for what’s right.
We have seen first-hand what’s happening inside Delaney Hall: law-abiding immigrants, including, mothers and fathers of US citizens, pastors, and pregnant women, being denied health care, food and due process. This is an absolute…
The bipartisan KIDS Act does just that. It is comprehensive legislation that addresses a problem everyone in Congress cares deeply about – keeping kids and teens safe online.